NA2010
GenElute™ Blood Genomic DNA Kit
sufficient for 70 purifications
Synonym(s):
Blood Genomic DNA, Gen Elute
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.55
UNSPSC Code:
41105501
usage
sufficient for 70 purifications
Quality Level
technique(s)
DNA purification: suitable
input
blood
test parameters
: <40 min kit run time, sample volume: 200 μL
storage temp.
15-25°C, room temp
General description
The GenElute Blood Genomic DNA kit provides a simple and convenient way to isolate pure genomic DNA from fresh or aged (older than 24 hours) whole blood. The kit combines the advantages of silica binding with a microspin format, and eliminates the need for expensive resins, alcohol precipitation, and hazardous organic compounds such as phenol and chloroform.
Application
GenElute™ Blood Genomic DNA Kit has been used:
- to extract DNA from samples of large granules (LG) and smaller granules (SG) obtained from vasectomized rabbits
- to isolate DNA from the blood samples
- to extract whole blood DNA from the left blood cells
The purified genomic DNA is ready for downstream applications such as:
- restriction endonuclease digestions
- PCR
- Southern blots
- sequencing reactions
- cloning
Biochem/physiol Actions
The starting material is lysed in a chaotropic salt-containing solution to ensure the thorough denaturation of macromolecules. The addition of ethanol causes the DNA to bind when the lysate is spun through a silica membrane in a microcentrifuge tube. A Prewash Solution is provided to help remove contaminants that are associated with aged (older than 24 hours) whole blood samples. After washing to remove contaminants, the DNA is eluted in 200 mL of a Tris-EDTA solution.
The expected yields of genomic DNA will vary depending on the amount and nature of the starting material used (for example, 4 to 10 μg of RNase A-treated DNA can be isolated from 200 μl of fresh whole blood in less than one hour). DNA purified with this kit has an A260/A280 ratio between 1.6 and 1.9 and can be up to 50 kb in length.
The expected yields of genomic DNA will vary depending on the amount and nature of the starting material used (for example, 4 to 10 μg of RNase A-treated DNA can be isolated from 200 μl of fresh whole blood in less than one hour). DNA purified with this kit has an A260/A280 ratio between 1.6 and 1.9 and can be up to 50 kb in length.
Features and Benefits
- Starting material: Up to 200 μl of fresh or aged blood
- Expected yield: Up to 10 μg
- Elution volume: 400 μl
- Time required: <40 min
- A260/A280 ratio: 1.6 - 1.9
- Compatible with many anticoagulants, including EDTA, Heparin, and Sodium Citrate
- Typical yields 4-10 μg from 200 μL of whole blood
- Pure genomic DNA with a A260/A280 ratio between 1.6 and 1.9
- Isolate DNA up to 50 kb in length
Other Notes
For additional information, please see www.sigma-aldrich.com/genomicdna.
Legal Information
GenElute is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under GenElute™ Blood Genomic DNA Kit
signalword
Danger
target_organs
Respiratory system
Storage Class
10 - Combustible liquids
wgk
WGK 3
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 2 - ED ENV 1 - Eye Dam. 1 - Resp. Sens. 1 - Skin Irrit. 2 - STOT SE 3
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
GenElute™ Blood Genomic DNA Kit
Sai Wang et al.
Frontiers in genetics, 11, 585064-585064 (2020-12-01)
Familial renal glucosuria is a rare renal tubular disorder caused by SLC5A2 gene variants. Most of them are exonic variants and have been classified as missense variants. However, there is growing evidence that some of these variants can be detrimental
Xiangzhong Zhao et al.
Scientific reports, 6, 33920-33920 (2016-09-27)
Familial renal glycosuria (FRG) is caused by mutations in the SLC5A2 gene, which codes for Na+-glucose co-transporters 2 (SGLT2). The aim of this study was to analyze and identify the mutations in 16 patients from 8 families with FRG. All
Yanxia Gao et al.
Renal failure, 36(8), 1226-1232 (2014-07-01)
The objective of this study is to identify ATP6V1B1, ATP6V0A4 and SLC4A1 genes mutations and assess audiologic characteristics in six Chinese children with primary distal renal tubular acidosis from four unrelated families between the ages of 2 and 13 years.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| NA2010-1KT | 04061835573721 |